Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Opendoor Technologies, Disclosing 6.5% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in Opendoor Technologies Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, reporting a passive beneficial ownership of 8.6% in Camden National Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% beneficial ownership stake in Ciena Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in Community Trust Bancorp, Filing Amended 13G
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 7.3% beneficial ownership stake in Community Trust Bancorp Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, disclosing a 7.1% passive beneficial ownership stake in Cooper Companies Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.0% Passive Stake in Copart Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.0% passive beneficial ownership stake in Copart Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 9.9% beneficial ownership stake in EchoStar CORP's Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.2% of Euronet Worldwide, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, reporting an 8.6% beneficial ownership stake in Fair Isaac Corporation as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, disclosing a 7.8% beneficial ownership stake in FARO Technologies Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Amends Schedule 13G, Disclosing 8.6% Stake in First Financial Corporation
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.6% in First Financial Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 17 to its Schedule 13G, reporting a beneficial ownership of 8.3% of the common stock of First of Long Island Corp as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Passive Stake in Five9, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.5% beneficial ownership stake in Five9, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.5% Stake in Fulcrum Therapeutics Inc. Through Latest SEC Filing
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 7.5% of the common stock of Fulcrum Therapeutics Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in H&E Equipment Services, Disclosing 6.8% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 8 to Schedule 13G, reporting a 6.8% beneficial ownership stake in H&E Equipment Services Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.0% Passive Stake in ENVIRI Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in ENVIRI Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in Hartford Insurance Group, Inc. at 8.5%
BlackRock, Inc. has filed an updated Schedule 13G, reporting a passive beneficial ownership of 8.5% of Hartford Insurance Group, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends HEICO Corp. Stake Disclosure, Maintaining 5.1% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 10 to its Schedule 13G, disclosing a 5.1% beneficial ownership stake in HEICO Corp. common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.8% Stake in Hims & Hers Health Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.8% of Hims & Hers Health Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Hologic Stake, Reports 8.9% Passive Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 8.9% of Hologic Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.9% Stake in Houlihan Lokey Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.9% of Houlihan Lokey, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 7.7% beneficial ownership stake in Humana Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Huntington Ingalls Industries Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, disclosing a beneficial ownership of 8.7% of Knight-Swift Transportation Holdings Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.0% Passive Stake in Kohl's Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.0% beneficial ownership stake in Kohl's Corp common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Kroger Stake, Disclosing 7.5% Passive Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 7.5% beneficial ownership stake in Kroger Co. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, confirming its continued beneficial ownership of 7.3% of Mercury General Corporation's common stock as a passive investor.
NYSE
SCHEDULE 13G/A: BlackRock Amends Significant Stake in Brookdale Senior Living, Reaffirming Passive Investment
BlackRock, Inc. has filed Amendment No. 6 to its Schedule 13G, disclosing a 7.3% beneficial ownership stake in Brookdale Senior Living Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 7.1% beneficial ownership stake in CVS Health Corporation as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in Charles River Laboratories International Inc. as of March 31, 2025.